Methods An electronic search was performed on PubMed and EMBASE to identify relevant
randomized controlled trials (RCTs) comparing DCBs and plain balloon angioplasty from …

Background: Despite the advent of newer stents, in-stent restenosis has been a persistent
and formidable challenge. Trials have demonstrated the superiority of drug-coated balloons …

Clinical failure of arteriovenous neointimal hyperplasia (NIH) fistulae (AVF) is frequently due
to juxta-anastomotic NIH (JANIH). Although the mouse AVF model recapitulates human AVF …

Background Anticoagulation and antiplatelet therapy effectively inhibit neointimal
hyperplasia (NIH) in both arterial and venous systems but not in arteriovenous fistulae …

Purpose A review of systematic reviews (SRs) and an update of the current meta-analysis
were conducted to evaluate the clinical efficacy and safety of drug-coated balloons (DCBs) …

Background: Arteriovenous fistula (AVF) was the lifeline of patients with maintenance
hemodialysis (MHD). However, stenosis of AVF may limit its use. Currently, AVF stenosis is …

Stenosis represents the most relevant arteriovenous fistula (AVF) pathology and can affects
the entire conduit forming the fistula, from afferent artery to central venous vessels …

Introduction To evaluate the efficacy and safety of paclitaxel‐coated balloon angioplasty in
the treatment of thrombosed arteriovenous fistulas. Methods This prospective, randomized …

Background: Plain old balloon angioplasty has been the mainstay of treatment for
arteriovenous fistula (AVF) stenoses. Recent studies suggest that drug coated balloons …

Percutaneous transluminal angioplasty (PTA), which enables longer patency of vascular
access in hemodialysis patients, is considered the standard of care for the treatment of …